Healthcare Services

Global Chronic Pancreatitis (CP) Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

March 31, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Chronic Pancreatitis (CP) Market Across 2026–2030?

The chronic pancreatitis (cp) market size has seen significant growth in recent years. It is projected to expand from $5.23 billion in 2025 to $5.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. The increase observed historically can be linked to better availability of diagnostic imaging, greater public awareness of pancreatic disorders, more widespread use of pain management therapies, the expansion of gastroenterology services, and enhanced supportive care options.

The chronic pancreatitis (cp) market is projected for substantial expansion in the upcoming years, with expectations to reach $7.05 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This anticipated growth during the forecast period is driven by factors such as the ongoing development of advanced enzyme formulations, a rising emphasis on early-stage intervention, the widening of outpatient treatment models, the increasing integration of nutrition-based therapies, and augmented investment in pancreatic disease research. Notable trends for this period encompass the expanded use of enzyme replacement therapies, a growing adoption of minimally invasive endoscopic treatments, an intensified focus on nutritional management, the broadening of personalized treatment plans, and an enhanced commitment to early diagnosis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Chronic Pancreatitis (CP) Market?

The growing intake of alcohol is anticipated to boost the chronic pancreatitis market in the future. Alcohol consumption involves consuming beverages with ethanol, often for recreational, social, or cultural reasons, but excessive use can lead to dependency or health problems. This rise in alcohol consumption is propelled by factors such as increased social acceptance, urbanization, evolving lifestyles, and stress management techniques, especially among younger demographics. Alcohol intake causes chronic pancreatitis by initiating inflammation and damage to pancreatic cells, resulting in fibrosis, ductal obstructions, and long-term dysfunction due to toxic metabolic byproducts. For instance, in 2025, the Priory Group, a UK-based provider of mental health, addiction, and specialist education services, conducted a 2023 survey revealing that 25% of UK individuals aged 18–24 now completely abstain from alcohol, indicating a significant trend towards sobriety within the younger generation. Therefore, the increasing consumption of alcohol is a key driver for the growth of the chronic pancreatitis market.

What Segmentation Levels Are Considered In The Chronic Pancreatitis (CP) Market?

The chronic pancreatitis (cp) market covered in this report is segmented –

1) By Treatment: Analgesic, Artificial Digestive Enzyme, Protein Supplements, Other Treatments

2) By Diagnosis: Computed Tomography (CT) Scan, Magnetic Resonance Cholangiopancreatography, Ultrasound Sonography, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospitals, Homecare, Other End Users

Subsegments:

1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids

2) By Artificial Digestive Enzyme: Pancrelipase, Pancreatin

3) By Protein Supplements: Branched-Chain Amino Acids (BCAA), Whey Protein

4) By Other Treatments: Endoscopic Treatment, Surgery

Which Trends Are Impacting The Growth Of The Chronic Pancreatitis (CP) Market?

Key players within the chronic pancreatitis market are directing their efforts towards creating innovative technological solutions, notably enzyme replacement therapy, to tackle exocrine pancreatic insufficiency (EPI) linked to chronic pancreatitis. This therapy entails the oral administration of pancreatic enzymes to assist digestion for individuals whose pancreatic function is inadequate. As an illustration, in July 2023, First Wave BioPharma Inc, a clinical-stage biopharmaceutical firm based in the US, disclosed the findings from its Phase 2 SPAN clinical trial, which examined an improved enteric microgranule delivery formulation of adrulipase for managing exocrine pancreatic insufficiency (EPI) in patients suffering from cystic fibrosis (CF) and chronic pancreatitis. Adrulipase, a recombinant lipase enzyme sourced from the Yarrowia lipolytica yeast, is provided as an oral, non-systemic biologic capsule, engineered to break down fat molecules within the digestive system of EPI patients, enabling their absorption as vital nutrients.

Which Leading Firms Are Contributing To The Growth Of The Chronic Pancreatitis (CP) Market?

Major companies operating in the chronic pancreatitis (cp) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy’s Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Read the full chronic pancreatitis (cp) market report here:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Which Regions Are Projected To Dominate The Chronic Pancreatitis (CP) Market In The Coming Years?

North America was the largest region in the chronic pancreatitis (CP) market in 2025. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Pancreatitis (CP) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21146&type=smp

Browse Through More Reports Similar to the Global Chronic Pancreatitis (CP) Market 2026, By The Business Research Company

Chronic Pain Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Virtual Reality In Healthcare Global Market Report

https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

Virtual Reality Vr In Medical Simulation Global Market Report

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-in-medical-simulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795